Jack D. Sobel
0000-0002-5589-4609
Publication & Citation Trends
Publications
0 total
Methodologic and analytic considerations in the CANDLE trial of ibrexafungerp for recurrent vulvovaginal candidiasis (Reply to Letter-to-the-Editor).
Cited by 0
Semantic Scholar
A Phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis.
Cited by 5
Semantic Scholar
Treatment of Male Sexual Partners of Women with Bacterial Vaginosis (BV); A Randomized, Double-Blind, Placebo-Controlled Trial. OA
Cited by 25
Semantic Scholar
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species
Cited by 144
Semantic Scholar
Antimicrobial Drug Resistance
Cited by 39
Semantic Scholar
Results from a phase 2, randomized, double‐blind, placebo‐controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis: 4
Cited by 7
Semantic Scholar
Vulvovaginal Candidiasis in Pregnancy
Cited by 145
Semantic Scholar
Coughing spells in a Michiganian girl after a trip to Southwest US. OA
Cited by 2
Semantic Scholar
Research Topics
Reproductive tract infections research
(296)
Antifungal resistance and susceptibility
(172)
Urinary Tract Infections Management
(95)
Nail Diseases and Treatments
(87)
Fungal Infections and Studies
(83)
Affiliations
University of the Sciences
Aga Khan University
Louisiana State University
Centers for Disease Control and Prevention
Royal Society